GC Cell, a trailblazer in the field of cell and gene therapy, is thrilled to announce the signing of a Memorandum of Understanding (MOU) with PT Bifarma Adiluhung, an affiliate of the renowned KALBE group. This strategic partnership brings together two industry leaders, combining GC Cell’s expertise in advanced therapeutics with Bifarma’s comprehensive capabilities in research and development, GMP-compliant manufacturing, and commercialization of cell therapies within Indonesia.
Through this collaboration, GC Cell and Bifarma aim to accelerate the development and accessibility of cutting-edge cell and gene therapies in the rapidly growing Indonesian market. By leveraging their complementary strengths, the companies seek to address the increasing demand for innovative healthcare solutions and improve patient outcomes across the region.